Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | January 2, 2017 |
| Target | Bactolife |
| Sector | Life Science |
| Investor(s) | EEP Advisers |
| Deal Type | Venture |
FILTER BY
EEP is a Venture Capital investment firm that provides both dedication and passion on top of the financial investment itself. With more than 25 years of investment experience in life sciences, EEP provides deep sectorial knowledge and an established network. EEP was founded in 1999 and is based in London, England.
| Deal Context for Investor | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Life Science | 3 of 3 |
| Type: Venture | 2 of 2 |
| Country: Denmark | 2 of 2 |
| Year: 2017 | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2016-12-20 |
AGC Biologics
Bothell, Washington, Denmark AGC Biologics is a global contract manufacturing and development (CDMO) company for biopharmaceuticals. AGC Biologics is based in Bothell, Washington. |
Sell | ¥60.0B |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-03-24 |
Azanta A/S
Valby, Denmark Azanta A/S is a privately-owned specialty pharma company primarily operating within oncology, women's health and addiction medicine. Azanta A/S currently markets (or makes available under special authorization) a portfolio of specialty pharmaceutical products, including Nimorazole a hypoxic radiosensitizer for the treatment of head and neck cancer patients undergoing primary radiotherapy and Angusta® for labor induction. |
Sell | - |
